SOCIAL HEALTH INSURANCE: HIGH QUALITY TREATMENT AND FINANCIAL SUSTAINABILITY
The overall goal for societies is to create good chances for health and well-being for all. The two main duties for public healthcare systems are to promote health and offer universal health coverage in case of illness. Recently a severe conflict arises between value based pricing and access to innovation.
Expensive drugs destabilize health systems and exclude people from necessary treatments in many countries. Modern, innovative pharmaceuticals often bring relevant improvements for patients (e.g. therapies for cancer or Hepatitis C) but the costs in most cases are exorbitant. The pricing strategies of the pharmaceutical industry create in some cases financial difficulties for health systems even in rich European countries and exclude patients from access to necessary treatments.
It will be a future key challenge to tackle this pressure on health systems and social health insurance providers, especially in the light of continuous demographic changes and migration that Europe is undergoing at the moment.